XML 59 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
GOODWILL AND INTANGIBLE ASSETS
9 Months Ended
Sep. 30, 2013
Goodwill and Intangible Assets Disclosure [Abstract]  
GOODWILL AND INTANGIBLE ASSETS
GOODWILL AND INTANGIBLE ASSETS

The changes in goodwill for the nine months ended September 30, 2013 and for the year ended December 31, 2012 are as follows:
 
September 30,
2013
 
December 31,
2012
Balance at beginning of period
$
5,535,848

 
$
5,795,765

Goodwill acquired during the period
130,192

 
28,144

Goodwill impairment and write-off associated with sale of businesses during the period
(37,103
)
 
(85,173
)
Reclassification to non-current assets held for sale

 
(218,795
)
(Decrease) increase related to foreign currency translation
(129
)
 
15,907

Balance at end of period
$
5,628,808

 
$
5,535,848



Approximately 90% of the Company’s goodwill as of September 30, 2013 and December 31, 2012 was associated with its DIS business.

For the nine months ended September 30, 2013, goodwill acquired was principally associated with the UMass, Dignity and ATN acquisitions, which is deductible for tax purposes. These acquisitions also resulted in $94.9 million of intangible assets, principally comprised of customer-related intangibles (see Note 5).

For the nine months ended September 30, 2013, goodwill written-off was associated with the sale of Enterix. In addition, intangible assets associated with the sale of Enterix with a net book value of $5.6 million were written-off. For further details regarding the sale of Enterix, see Note 6.

For the year ended December 31, 2012, goodwill acquired was principally associated with the acquisition of S.E.D. Medical Laboratories. Approximately $28 million and $19 million, respectively, represented goodwill, which is deductible for tax purposes, and intangible assets, principally comprised of customer-related intangibles.

For the year ended December 31, 2012, goodwill impairment was associated with HemoCue and the write-off of goodwill was associated with the sale of OralDNA during the fourth quarter of 2012. For further details regarding goodwill included in non-current assets held for sale, see Note 18 to the Consolidated Financial Statements in the Company's 2012 Annual Report on Form 10-K.    
    
Intangible assets at September 30, 2013 and December 31, 2012 consisted of the following:

 
Weighted
Average
Amortization
Period
(in Years)
 
September 30, 2013
 
December 31, 2012
 
 
 
Cost
 
Accumulated
Amortization
 
Net
 
Cost
 
Accumulated
Amortization
 
Net
Amortizing intangible assets:
 
 

 
 

 
 

 
 

 
 

 
 

Customer-related intangibles
18
 
$
657,901

 
$
(200,194
)
 
$
457,707

 
$
566,701

 
$
(173,516
)
 
$
393,185

Non-compete agreements
4
 
41,731

 
(24,405
)
 
17,326

 
38,551

 
(17,123
)
 
21,428

Technology
14
 
119,440

 
(25,714
)
 
93,726

 
131,040

 
(25,144
)
 
105,896

Other
8
 
143,807

 
(54,086
)
 
89,721

 
141,818

 
(37,634
)
 
104,184

Total
16
 
962,879

 
(304,399
)
 
658,480

 
878,110

 
(253,417
)
 
624,693

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Intangible assets not subject to amortization:
 
 

 
 

 
 

 
 

 
 

Tradenames
 
 
244,000

 

 
244,000

 
246,200

 

 
246,200

In-process research and development
 
 
120

 

 
120

 
120

 

 
120

Other
 
 
1,299

 

 
1,299

 
1,159

 

 
1,159

Total intangible assets
 
$
1,208,298

 
$
(304,399
)
 
$
903,899

 
$
1,125,589

 
$
(253,417
)
 
$
872,172



Amortization expense related to intangible assets was $20.2 million and $18.6 million for the three months ended September 30, 2013 and 2012, respectively. For the nine months ended September 30, 2013 and 2012, amortization expense related to intangible assets was $59.2 million and $56.2 million, respectively.
 
The estimated amortization expense related to amortizable intangible assets for each of the five succeeding fiscal years and thereafter as of September 30, 2013 is as follows:

Year Ending December 31,
 

Remainder of 2013
$
19,932

2014
76,657

2015
65,335

2016
58,980

2017
56,000

2018
48,751

Thereafter
332,825

Total
$
658,480